CLINICAL STUDY OF TA-058

TA-058, new semisynthetic penicillin, was administered to 8 severe infections cases suffering from malignant neoplasms of the hematopoietic organs. Daily doses of TA-058 was 4 to 8 grams, and clinical efficacy was excellent in 1 case, good in 1 case, poor in 5 cases and undecided in 1 case. No serio...

Full description

Saved in:
Bibliographic Details
Published in:CHEMOTHERAPY Vol. 32; no. Supplement2; pp. 356 - 358
Main Authors: SHIBATA, HIROTOSHI, KUBOTA, RYOJI, TANAKA, TERUKAZU, UEDA, TAKAAKI, TAKUBO, TAKAYUKI, NAKAMURA, HIROYUKI, MASAOKA, TORU
Format: Journal Article
Language:English
Japanese
Published: Japanese Society of Chemotherapy 1984
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:TA-058, new semisynthetic penicillin, was administered to 8 severe infections cases suffering from malignant neoplasms of the hematopoietic organs. Daily doses of TA-058 was 4 to 8 grams, and clinical efficacy was excellent in 1 case, good in 1 case, poor in 5 cases and undecided in 1 case. No serious side effects were observed.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.32.Supplement2_356